Transcatheter Heart Valve Therapies: From TAVR to Emerging Percutaneous Approaches

This chapter offers an in-depth analysis of the evolution, current evidence base, and future trajectory of transcatheter heart valve interventions, with a primary focus on transcatheter aortic valve replacement (TAVR) and its expanding indications across low-, intermediate-, and high-risk surgical populations. The review addresses valve design innovations, patient selection criteria, outcomes data from landmark randomized controlled trials, and the parallel development of transcatheter mitral and tricuspid valve technologies. Special attention is given to the implications of these technologies for the surgical management of valvular heart disease.